Revised: 10 June 2025

About Medsafe

What's New

Dear Healthcare Professional Letters
Ventolin (PDF, 2 pages, 200 KB)

Safety Information

Dear Healthcare Professional Letters
Estradiol (Mylan) (PDF, 3 pages, 352 KB)
Zyprexa IM (PDF, 2 pages, 226 KB

Medicines
Policy Statements
Early notification of potential medicine supply issues

Committees
Medicines Classification Committee
Minutes of the 73rd meeting of the Medicines Classification Committee - 26 February 2025
Comments on agenda items for the 73rd meeting of the Medicines Classification Committee
Dates and Deadlines

Information for Industry
Regulatory Consultants

Compliance
Pharmacy licensing
Pharmacy Licence Register

Committees
Medicines Adverse Reaction
Minutes of the 201th Medicines Adverse Reactions Committee Meeting
MARC Reports from the 201th Medicines Adverse Reactions Committee Meeting

Safety Information
Monitoring Communication
Update - Direct acting oral anticoagulants and potential for patients to experience mood changes (monitoring closed February 2025)

Safety Information
Dear Healthcare Professional Letters
Topamax (topiramate): New restrictions to prevent exposure during pregnancy (PDF, 4 pages, 143KB)

Medicines
Approval Process
Medsafe Industry Virtual Meetings

Safety Information
Alert Communication
Ayurvedic medicines update

Safety Information
Dear Healthcare Professional Letters
Important information: VENOFER® (iron sucrose) 20 mg /mL solution for injection INTERIM PACKAGING